Real-world evidence of BioMime sirolimus-eluting stent in obstructive coronary artery disease: the meriT-2 trial
The long-term clinical outcomes of the meriT-2 trial established the safety and efficacy of the ultrathin-strut biodegradable-polymer-based BioMime SES with satisfactory clinical outcomes at 5 years.
Authors
- Sunita Abraham
- Suhas Hardas (ORCID: https://orcid.org/0000-0001-8044-1188)
- Gurpreet Singh Wander (ORCID: https://orcid.org/0000-0002-4596-4247)
- Ashokkumar Thakkar
- Upendra Kaul (ORCID: https://orcid.org/0000-0002-4798-7098)
- Udita Chandra (ORCID: https://orcid.org/0000-0002-5957-4741)
- S.G. Vijan
- Manjunath C Nanjappa
- Thomas Alexander
- Rohit Manoj
- Prabhakar Heggunje-Shetty
- Ajit S. Mullasari
- Samuel Mathew
Institutions
- Apollo Hospitals (IN)
- Madras Medical Mission (IN)
- Sri Jayadeva Institute of Cardiovascular Sciences and Research (IN)
- Narayana Health (IN)
- Dayanand Medical College & Hospital (IN)
- Kovai Medical Center and Hospital (IN)
- Batra Hospital and Medical Research Centre (IN)
- Meril Life Sciences (India) (IN)
- Fortis Hospital (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Institute of Medical Sciences (IN)
- Columbia Asia (IN)
Publication Details
- Journal
- AsiaIntervention
- Published
- 2024-09-01
- DOI
- https://doi.org/10.4244/aij-d-24-00007
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00